Rochester General Hospital Introduces New Technology to Treat Peripheral Artery Disease

January 29, 2015

Rochester General Hospital, an affiliate of Rochester Regional Health System, is the first in the area to use the Lutonix Drug Coated Balloon Catheter to treat Peripheral Artery Disease (PAD).

PAD is a life-threatening condition that affects millions of Americans by narrowing arteries and reducing blood flow to the limbs. Worldwide it is estimates that 200 million people suffer from PAD.

Peripheral Artery Disease

“Minimally-invasive endovascular procedures such as angioplasty balloons and stents, medications and vascular bypass surgery are some of the accepted ways to treat PAD,” said Jeffrey Rhodes MD, a Vascular Surgeon at Rochester General. “What makes the Lutonix Catheter unique is the drug coating, which is designed to prevent scaring once the arteries are opened by the balloon catheter.”

Left untreated, Peripheral Artery Disease (PAD) can result in the loss of limbs. In fact, PAD is the leading cause of amputation in people over the age of 50 and accounts for up to 90% of amputations overall.

For more information on this latest technology and how it may benefit you or a loved one, please call Vascular Surgery Associates at 922-5550.

Recent News

Vascular_Penfield
Located at 30 Hagen Drive, the newest vascular location offers state-of-the-art technology to its patients.

Wednesday, May 15, 2019

New Vascular Office Opens in Penfield

Located at 30 Hagen Drive, the newest vascular location offers state-of-the-art technology to its patients.

Read News Article
Ticks_Scott_Allan
Immediate Care locations averaging higher numbers than usual.

Wednesday, May 15, 2019

Ticks On The Rise

Immediate Care locations averaging higher numbers than usual.

Read News Article
View All Recent News Articles